DrugDev Sponsors and Keynotes Pharma Industry Conferences as it Drives Disruption in Global Clinical Operations

Share Article

President and CEO Ibraheem Mahmood to keynote MAGI’s Clinical Research Conference; DrugDev sponsors ACRP Global Conference and Exposition

News Image
DrugDev President and CEO Ibraheem Mahmood keynotes: “What Will the Clinical Research Enterprise Look Like in 10 Years?” at MAGI East

DrugDev will promote the adoption of technology-driven solutions that enable sponsors, CROs and sites to collaborate on more clinical trials at key pharma industry events this month.

MAGI Clinical Research Conference, 17-20 May, Arlington VA

DrugDev President and CEO Ibraheem (Ibs) Mahmood will present the keynote address Monday 18 May, 8:30am EDT. In his presentation “What Will the Clinical Research Enterprise Look Like in 10 Years?” Ibs, who will be joined by Ira Spector, BSEE PhD, Executive Vice President, Analytics & Consulting, ICON plc, will discuss whether clinical research is changing rapidly or we are wrestling with the same old problems, what the future might hold, and how we can prepare.

Margaret M. (Peg) Tierney, BA, Paralegal, and DrugDev SiteStart Senior Contracts Manager, will present “Sensible Payment Terms in CTAs,” with John P. Haeger, CRCP,
Lead Contract Analyst at the Sarah Cannon Research Institute. Peg and John will discuss the 7 payment terms sponsors and sites need to know, Monday at 3:45pm EDT.

Annual ACRP Global Conference and Exposition, 25-28 April Salt Lake City

DrugDev will sponsor and exhibit at ACRP. We invite representatives of clinical investigator sites that want to do more trials, do less paperwork and be paid more quickly to visit booth #604 and register for the complimentary DrugDev network. DrugDev representatives will also be interviewing clinical site professionals on why they are passionate about clinical research for our website.

About DrugDev

DrugDev is an innovative technology company which provides cloud-based solutions to help sponsors, CROs and investigators do more clinical trials together. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration and powers the TransCelerate Investigator Registry. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials at drugdev.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brenda Nashawaty
+1 617-688-3253
Email >

Kristopher Sarajian
617-952-4071 132
Email >
Follow >